GSA Capital Partners’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$65K Buy
2024
Q3
$351K Buy
2024
Q2
$324K Buy
2024
Q1
$480K Sell
2023
Q4
$764K Sell
2023
Q3
$586K Sell
2023
Q2
$668K Buy
2023
Q1
$141K Sell
2022
Q4
$428K Buy
2022
Q1
Sell
2021
Q4
$393K Buy